These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8512582)

  • 1. Inhibition of catechol-O-methyltransferase by 1-vinyl derivatives of nitrocatechols and nitroguaiacols. Kinetics of the irreversible inhibition by 3-(3-hydroxy-4-methoxy-5-nitro benzylidene)-2,4-pentanedione.
    Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
    Biochem Pharmacol; 1993 May; 45(10):1973-81. PubMed ID: 8512582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and inhibition studies on catechol-O-methyltransferase affinity labelling by N-(3,4-dihydroxyphenyl)maleimide.
    Piedrafita FJ; Fernandez-Alvarez E; Nieto O; Tipton KF
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):951-8. PubMed ID: 1417755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of the reversible tight-binding inhibition of pig liver catechol-O-methyltransferase by [2-(3,4-dihydroxy-2- nitrophenyl)vinyl]phenyl ketone.
    Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
    J Enzyme Inhib; 1994; 8(2):123-31. PubMed ID: 7539072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: synthesis and biological activity as catechol-O-methyltransferase inhibitors.
    Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
    J Med Chem; 1992 Nov; 35(24):4584-8. PubMed ID: 1469689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of catechol-O-methyltransferase by N-(3,4-dihydroxyphenyl) maleimide.
    Piedrafita FJ; Elorriaga C; Fernández-Alvarez E; Nieto O
    J Enzyme Inhib; 1990; 4(1):43-50. PubMed ID: 2128841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols.
    Ovaska M; Yliniemelä A
    J Comput Aided Mol Des; 1998 May; 12(3):301-7. PubMed ID: 9749372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
    Brannan T; Prikhojan A; Yahr MD
    J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tolcapone upon soluble and membrane-bound brain and liver catechol-O-methyltransferase.
    Vieira-Coelho MA; Soares-da-Silva P
    Brain Res; 1999 Mar; 821(1):69-78. PubMed ID: 10064789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of new inhibitors of catechol-O-methyl transferase.
    Rivas E; de Ceballos ML; Nieto O; Fontenla JA
    Br J Pharmacol; 1999 Apr; 126(7):1667-73. PubMed ID: 10323601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease.
    Patel CN; Georrge JJ; Modi KM; Narechania MB; Patel DP; Gonzalez FJ; Pandya HA
    J Biomol Struct Dyn; 2018 Nov; 36(15):3938-3957. PubMed ID: 29281938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of bifunctional nitrocatechol inhibitors of pig liver catechol-O-methyltransferase.
    Bailey K; Tan EW
    Bioorg Med Chem; 2005 Oct; 13(20):5740-9. PubMed ID: 16002297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catechol O-methyltransferase. 11. Inactivation by 5-hydroxy-3-mercapto-4-methoxybenzoic acid.
    Borchardt RT; Huber JA
    J Med Chem; 1982 Mar; 25(3):321-3. PubMed ID: 7069707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT).
    Masjost B; Ballmer P; Borroni E; Zürcher G; Winkler FK; Jakob-Roetne R; Diederich F
    Chemistry; 2000 Mar; 6(6):971-82. PubMed ID: 10785817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling and metabolic studies of the interaction of catechol-O-methyltransferase and a new nitrocatechol inhibitor.
    Palma PN; Bonifácio MJ; Loureiro AI; Wright LC; Learmonth DA; Soares-da-Silva P
    Drug Metab Dispos; 2003 Mar; 31(3):250-8. PubMed ID: 12584150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and crystal structure of catechol-o-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application.
    Bonifácio MJ; Archer M; Rodrigues ML; Matias PM; Learmonth DA; Carrondo MA; Soares-Da-Silva P
    Mol Pharmacol; 2002 Oct; 62(4):795-805. PubMed ID: 12237326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-O-methyltransferase.
    Learmonth DA; Vieira-Coelho MA; Benes J; Alves PC; Borges N; Freitas AP; da-Silva PS
    J Med Chem; 2002 Jan; 45(3):685-95. PubMed ID: 11806720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisubstrate inhibitors for the enzyme catechol-O-methyltransferase (COMT): influence of inhibitor preorganisation and linker length between the two substrate moieties on binding affinity.
    Lerner C; Masjost B; Ruf A; Gramlich V; Jakob-Roetne R; Zürcher G; Borroni E; Diederich F
    Org Biomol Chem; 2003 Jan; 1(1):42-9. PubMed ID: 12929389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl conjugation in uraemia: catechol-O-methyltransferase.
    Pazmiño PA; Weinshilboum RM
    Br J Clin Pharmacol; 1980 Nov; 10(5):509-18. PubMed ID: 7437264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies.
    Chen D; Wang CY; Lambert JD; Ai N; Welsh WJ; Yang CS
    Biochem Pharmacol; 2005 May; 69(10):1523-31. PubMed ID: 15857617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.